Our Research

Cystic Fibrosis

Cystic Fibrosis is really important

People

  • Brendan O'Fallon

Selected papers

  • T. G. Liou, N. Argel, F. Asfour, P. S. Brown, B. A. Chatfield, D. R. Cox, C. L. Daines, D. Durham, J. A. Francis, B. Glover, et al. Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis. IScience, 27, 2024.
  • T. G. Liou, N. Argel, F. Asfour, P. S. Brown, B. A. Chatfield, D. R. Cox, C. L. Daines, D. Durham, J. B. Francis, B. Glover, et al. Associations of sputum biomarkers with clinical outcomes in people with cystic fibrosis. medRxiv, 2022.
  • T. G. Liou, C. Kartsonaki, R. H. Keogh, and F. R. Adler. Evaluation of a five-year predicted survival model for cystic fibrosis in later time periods. Scientific Reports, 10:1--11, 2020.
  • T. G. Liou, F. R. Adler, N. Argel, F. Asfour, P. S. Brown, B. A. Chatfield, C. L. Daines, D. Durham, J. A. Francis, B. Glover, et al. Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis. BMC Med. Res. Method., 19:88, 2019.
  • A. M. Granchelli, F. R. Adler, R. H. Keogh, C. Kartsonaki, D. R. Cox, and T. G. Liou. Microbial interactions in the cystic fibrosis airway. J. Clin. Microbiol., 56:e00354--18, 2018.
  • J. L. Jensen, C. R. Jones, C. Kartsonaki, K. A. Packer, F. R. Adler, and T. G. Liou. Sleep phase delay in cystic fibrosis: A potential new manifestation of cystic fibrosis transmembrane regulator dysfunction. Chest, 152:386--393, 2017.
  • F. R. Adler and T. G. Liou. The dynamics of disease progression in cystic fibrosis. PLoS One, 11:e0156752, 2016.
  • T. G. Liou, F. R. Adler, R. H. Keogh, Y. Li, J. L. Jensen, W. Walsh, K. Packer, T. Clark, H. Carveth, J. Chen, S. L. Rogers, C. Lane, J. Moore, A. Sturrock, R. Paine III, D. R. Cox, and J. R. Hoidal. Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis. PLoS One, 7:e42748, 2012.
  • T. G. Liou, F. R. Adler, D. R. Cox, and B. C. Cahill. Lung transplantation and survival in children with cystic fibrosis. New Eng. J. Med., 357:2143--2152, 2007.
  • T. G. Liou, F. R. Adler, and D. Huang. Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am. J. Crit. Care Respir. Med., 171:1053--1059, 2005.
  • T. G. Liou, F. R. Adler, B. C. Cahill, S. C. FitzSimmons, D. Huang, J. R. Hibbs, and B. C. Marshall. Priorities for lung transplantation among patients with cystic fibrosis. J. Am. Med. Assoc., 287:1525, 2002.
  • T. G. Liou, B. C. Cahill, F. R. Adler, and B. C. Marshall. Selection of patients with cystic fibrosis for lung transplantation. Current Opinion in Pulmonary Medicine, 8:535--541, 2002.
  • T. G. Liou, F. R. Adler, B. C. Cahill, S. C. FitzSimmons, J. R. Hibbs, and B. C. Marshall. A predictive 5-year survivorship model of cystic fibrosis. Am. J. Epidemiol., 153:345--352, 2001.
  • T. G. Liou, F. R. Adler, B. C. Cahill, S. C. FitzSimmons, D. Huang, J. R. Hibbs, and B. C. Marshall. Survival effect of lung transplantation among patients with cystic fibrosis. J. Am. Med. Assoc., 286:2683--2689, 2001.